Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues

    NEXT STORY
    Cellectis Reports Clinical Hold Placed on MELANI-01 Study
    PREV STORY
    Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen System
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update

    – Successfully completed two positive Phase 3 pivotal efficacy studies of OLINVO™ (oliceridine injection) ...

    author_avatar
    NASDAQ Market News

    ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights

    -- Large, controlled clinical trial of avacopan in Hidradenitis Suppurativa (HS) on track to ...

    author_avatar
    NASDAQ Market News

    PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Surgery

    author_avatar
    NASDAQ Market News